Currently, the new crown influenza virus is predominantly the Omicron strain, which is not fatal in most cases, but still poses a fatal risk in new crown patients who are elderly, have underlying medical conditions, and have not been vaccinated against the new crown.
By constantly mutating, the performance of the virus cannot be determined, and the direction of mutation is random, the neo-crown virus may become a common respiratory infection like the influenza virus, or it may become more deadly.
The new crown vaccine, if it continues to be upgraded and modernized, will be able to control and resist the infection and transmission of the new crown virus to a certain extent and reduce the lethality.
However, for patients with underlying diseases such as coronary heart disease, tumors, diabetes, or elderly patients who have not been vaccinated with the NeoCrown vaccine, there is a possibility of serious infection or death.
With epidemiological history and symptoms such as fever, dry cough, malaise, and loss of taste, it is recommended to seek prompt medical attention and cause-specific treatment under the guidance of a specialist.